Don't miss


Friday, April 29, 2016

DSM Sinochem Pharmaceuticals appoints Anurag Roy as its new Business Unit Director Asia Pacific, Middle East and Africa


By on Friday, April 29, 2016



DSM Sinochem Pharmaceuticals appoints Anurag Roy as its new Business Unit Director Asia Pacific, Middle East and Africa


DSM Sinochem Pharmaceuticals, the global leader in sustainable antibiotics, next generation statins and anti-fungals, has appointed Anurag Roy as its new Business Unit Director for Asia Pacific, Middle East and Africa. He will also be the Global Product Owner, New API.

Anurag is a seasoned chemical, pharmaceutical and life sciences industry professional, having acquired a wealth of business and product management experience during his 17 years of strategic, operational and financial leadership. 

He has an excellent track record in uniquely challenging global and indigenous business environments, specifically in forging strategic partnerships with innovators, driving organizational profit and establishing credibility. 
Anurag Roy,
Business Unit Director for Asia Pacific,
Middle East and Africa
Anurag has previously held senior management positions at various companies, most recently as Vice President, Custom Pharmaceuticals Services, Dr. Reddy’s Laboratories (DRL). He also has experience of escalating business growth at three US-based companies, BASE-SAF, a chemical manufacturer; ORC International, a market research consultancy and Frost and Sullivan, the global growth consulting firm. 

His areas of expertise have, therefore, encompassed driving business, strategic marketing, and motivating cross functional global teams for peak performance, mergers, acquisitions and new ventures.

Anurag holds an MBA from Columbia Business School, New York, USA. He has authored several articles which have appeared in leading publications such as LA Times, Chemical Week, Modern Plastics, International Journal of Polymer Sciences, Economic Times & Business India. He has also presented scientific papers and has been a key spokesperson at several international conferences.

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next generation statins and anti-fungals. DSP develops, produces and sells raw materials, intermediates, active pharmaceutical ingredients and drug products. 

Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the competition.  

Headquartered in Singapore, the group has operations in China, India, Egypt, the Netherlands, Spain, the US and Mexico. DSP is a 50/50 Joint Venture of Royal DSM, a global science-based company active in health, nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.

Please visit www.dsm-sinochem.com for more information.




DSM Sinochem Pharmaceuticals
Business Unit AMEA
email info@dsm-sinochem.com
www.dsm-sinochem.com




For more information, please contact:

DSMSinochem Pharmaceuticals
Avian Media
S    Suman Sharma: + 91 – 96195 52810






Krishna: +91-9442191717

Srinija, +91 - 9789059528




About Myreality.in

www.myreality.in Your Investment Friend Persosal Finance, Real estate - plot,flats, home loan, income tax, laws and rules, builders, promoters, vastu rules, meaning of real estate terms, affordable housing, construction materials, insurance, real estate - events and surveys, also share market, mutual fund, insurance and world important days.

0 comments :

Google+ Followers

MOST READ

Popular Posts 7 Days